Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06398652
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-05-01
Brief Title:
Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis
Sponsor:
Taizhou Mabtech Pharmaceutical CoLtd
Organization:
Taizhou Mabtech Pharmaceutical CoLtd
Organization Data
Organization:
Taizhou Mabtech Pharmaceutical CoLtd
Class:
INDUSTRY
Study ID:
CMAB015-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taizhou Mabtech Pharmaceutical CoLtd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None